| LTH | lactogenic hormone; local tumor hyperthermia; low temperature holding; luteotropic hormone |
|---|---|
| MH | malignant histiocytosis; malignant hyperpyrexia; malignant hypertension; malignant hyperthermia; mam... |
| MRH | melanocyte-stimulating hormone-releasing hormone; multicentric reticulohistiocytosis |
| MRIH | melanocyte[-stimulating hormone] release-inhibiting hormone |
| MSH | medical self-help; melanocyte-stimulating hormone; melanophore-stimulating hormone |
| combined modality therapy | <oncology> Two or more types of treatments used to supplement each other. For instance, surgery, radiation, chemotherapy, hormonal or immunotherapy may be used alternatively or together for maximum effectiveness. (09 Oct 1997) |
|---|---|
| placental growth hormone | human placental lactogen |
| motion therapy, continuous passive | Movement of a body part initiated and maintained by a mechanical or electrical device to restore normal range of motion to joints, muscles, or tendons after surgery, prosthesis implantation, contracture flexion, or long immobilization. (12 Dec 1998) |
| plasma therapy | Treatment with plasma. (05 Mar 2000) |
| msh release-inhibiting hormone | <chemical> An oligopeptide hormone produced in the hypothalamus that inhibits the release of melanocyte-stimulating hormone (msh). Chemical name: Melanostatin (12 Dec 1998) |
| msh-releasing hormone | A polypeptide hormone which originates in the hypothalamus and stimulates secretion of melanocyte-stimulating hormones in the pituitary gland. (12 Dec 1998) |
| mud therapy | The therapeutic use of mud in packs or baths. It includes mud, earth, clay, and peat. The original mud was fango, a volcanic mud from the battaglia thermal springs in italy, applied externally in the treatment of rheumatism and other diseases of the joints and muscles. (12 Dec 1998) |
| play therapy | A treatment technique utilizing play as a medium for expression and communication between patient and therapist. (12 Dec 1998) |
| conditioning therapy | The application of modern theories of learning and conditioning in the treatment of behaviour disorders. (12 Dec 1998) |
| conjoint therapy | A type of therapy in which a therapist sees the two spouses, or parent and child, or other partners together in joint sessions. (05 Mar 2000) |
| convulsive therapy | The use of convulsive agents to influence favourably the course of a mental disorder. It is used primarily in the treatment of severe affective disorders and schizophrenia. (12 Dec 1998) |
| music therapy | <psychiatry> A form of distraction that uses music as an aid to relaxation. (16 Dec 1997) |
| corpus luteum hormone | <biochemistry, gynaecology> Produced in the corpus luteum, as an antagonist of oestrogens. Promotes proliferation of uterine mucosa and the implantation of the blastocyst, prevents further follicular development. (18 Nov 1997) |
| corpus luteum hormone unit | The progestational activity of 1 mg of unit of progestational activity; standard preparation of pure progesterone. See: Clauberg test, Corner-Allen unit. Synonym: corpus luteum hormone unit, unit of luteinizing activity. (05 Mar 2000) |
| corticotropic hormone | The hormone of the anterior lobe of the hypophysis which governs the nutrition and growth of the adrenal cortex, stimulates it to functional activity, and also possesses extraadrenal adipokinetic activity; it is a polypeptide containing 39 amino acids, but exact structure varies from one species to another; sometimes prefixed by a to distinguish it from beta-corticotropin. The first thirteen amino acids at the N-terminal region are identical to alpha-melanotropin. Synonym: adrenocorticotropin, adrenotropic hormone, adrenotropin, corticotropic hormone, corticotropin. (05 Mar 2000) |